Cytokine regulation of AMPK signaling

Frontiers in Bioscience

Volumn 14, Issue 5, 2009, Pages 1902-1916

  Steinberg, Gregory R ^a   Watt, Matthew J ^a   Febbraio, Mark A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Adiponectin; CNTF; Cytokines; Ghrelin; IL 6; Insulin sensitivity; Leptin; Nutrient signalling; Obesity; Resistin; TNF

Indexed keywords

MAMMALIA;

CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL; APPETITE; ENZYMOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APPETITE; CYTOKINES; HUMANS; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 63849111995     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3350     Document Type: Article

References (165)

1. Hawley, S., J. Boudeau, J. Reid, K. Mustard, L. Udd, T. Makela, D. Alessi & D. G. Hardie: Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMPactivated protein kinase cascade. Journal of Biology, 2, 28 (2003).
2. Woods, A., S. R. Johnstone, K. Dickerson, F. C. Leiper, L. G. Fryer, D. Neumann, U. Schlattner, T. Wallimann, M. Carlson & D. Carling: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol, 13, 2004-2008 (2003). (Pubitemid 37425212)
3. Shaw, R. J., M. Kosmatka, N. Bardeesy, R. L. Hurley, L. A. Witters, R. A. DePinho & L. C. Cantley: Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. PNAS, 101, 3329-3335 (2004). (Pubitemid 38338195)
4. Hurley, R. L., K. A. Anderson, J. M. Franzone, B. E. Kemp, A. R. Means & L. A. Witters: The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem, 280, 29060-6 (2005). (Pubitemid 41161355)
5. Woods, A., K. Dickerson, R. Heath, S. P. Hong, M. Momcilovic, S. R. Johnstone, M. Carlson & D. Carling: Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab, 2, 21-33 (2005). (Pubitemid 43239822)
6. Hawley, S. A., D. A. Pan, K. J. Mustard, L. Ross, J. Bain, A. M. Edelman, B. G. Frenguelli & D. G. Hardie: Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab, 2, 9-19 (2005). (Pubitemid 43239821)
7. Momcilovic, M., S. P. Hong & M. Carlson: Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem, 281, 25336-43 (2006). (Pubitemid 44401921)
8. Sakamoto, K., A. McCarthy, D. Smith, K. A. Green, D. Grahame Hardie, A. Ashworth & D. R. Alessi: Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. Embo J, 24, 1810-20 (2005). (Pubitemid 40769500)
9. Koh, H. J., D. E. Arnolds, N. Fujii, T. T. Tran, M. J. Rogers, N. Jessen, Y. Li, C. W. Liew, R. C. Ho, M. F. Hirshman, R. N. Kulkarni, C. R. Kahn & L. J. Goodyear: Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol, 26, 8217-27 (2006). (Pubitemid 44748559)
10. Thomson, D. M., B. B. Porter, J. H. Tall, H. J. Kim, J. R. Barrow & W. W. Winder: Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am J Physiol Endocrinol Metab, 292, E196-202 (2007). (Pubitemid 46052942)
11. Shaw, R. J., K. A. Lamia, D. Vasquez, S. H. Koo, N. Bardeesy, R. A. Depinho, M. Montminy & L. C. Cantley: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science, 310, 1642-6 (2005). (Pubitemid 41780780)
12. Hardie, D. G., D. Carling & M. Carlson: The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the Eukaryotic cell? Annu Rev Biochem, 67, 821-855 (1998). (Pubitemid 28411146)
13. Amodeo, G. A., M. J. Rudolph & L. Tong: Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1. Nature, 449, 492-5 (2007). (Pubitemid 47509541)
14. Xiao, B., R. Heath, P. Saiu, F. C. Leiper, P. Leone, C. Jing, P. A. Walker, L. Haire, J. F. Eccleston, C. T. Davis, S. R. Martin, D. Carling & S. J. Gamblin: Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature, 449, 496-500 (2007). (Pubitemid 47509548)
15. Townley, R. & L. Shapiro: Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase. Science, 315, 1726-9 (2007). (Pubitemid 46515629)
16. Davies, S. P., N. R. Helps, P. T. Cohen & D. G. Hardie: 5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett., 377, 421-425 (1995). (Pubitemid 26027159)
17. Sanders, M. J., P. O. Grondin, B. D. Hegarty, M. A. Snowden & D. Carling: Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J (2006).
18. Savage, D. B., K. F. Petersen & G. I. Shulman: Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev, 87, 507-20 (2007). (Pubitemid 47084679)
19. Kahn, B. B., T. Alquier, D. Carling & D. G. Hardie: AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism, 1, 15-25 (2005). (Pubitemid 43960587)
20. Steinberg, G. R. & S. B. Jorgensen: The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem, 7, 519-26 (2007).
21. Carling, D., V. A. Zammit & D. G. Hardie: A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett, 223, 217-22 (1987).
22. Saha, A. K., A. J. Schwarsin, R. Roduit, F. Masse, V. Kaushik, K. Tornheim, M. Prentki & N. B. Ruderman: Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5- aminoimidazole-4-carboxamide-1-beta - D-ribofuranoside. J Biol Chem, 275, 24279-24283 (2000). (Pubitemid 30626516)
23. Watt, M. J., G. R. Steinberg, S. Chan, A. Garnham, B. E. Kemp & M. A. Febbraio: β-adrenergic stimulation of skeletal muscle HSL can be overridden by AMPK signaling. FASEB J., 18, 1445-1446 (2004). (Pubitemid 39561609)
24. Muoio, D. M., K. Seefeld, L. A. Witters & R. A. Coleman: AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J., 338, 783-91 (1999). (Pubitemid 29140087)
25. Garton, A. J., D. G. Campbell, D. Carling, D. G. Hardie, R. J. Colbran & S. J. Yeaman: Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur J Biochem, 179, 249-254 (1989). (Pubitemid 19097684)
26. Kramer, H. F., C. A. Witczak, N. Fujii, N. Jessen, E. B. Taylor, D. E. Arnolds, K. Sakamoto, M. F. Hirshman & L. J. Goodyear: Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle. Diabetes, 55, 2067-2076 (2006). (Pubitemid 44509981)
27. Thong, F. S., P. J. Bilan & A. Klip: The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes, 56, 414-23 (2007).
28. Treebak, J. T., S. Glund, A. Deshmukh, D. K. Klein, Y. C. Long, T. E. Jensen, S. B. Jorgensen, B. Viollet, L. Andersson, D. Neumann, T. Wallimann, E. A. Richter, A. V. Chibalin, J. R. Zierath & J. F. P. Wojtaszewski: AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits. Diabetes, 55, 2051-2058 (2006). (Pubitemid 44509979)
29. Jakobsen, S. N., D. G. Hardie, N. Morrice & H. E. Tornqvist: 5'-AMP-activated Protein Kinase Phosphorylates IRS-1 on Ser-789 in Mouse C2C12 Myotubes in Response to 5-Aminoimidazole-4- carboxamide Riboside. J Biol Chem, 276, 46912-46916 (2001).
30. Winder, W. W., B. F. Holmes, D. S. Rubink, E. B. Jensen, M. Chen & J. O. Holloszy: Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J.Appl.Physiol., 88, 2219-2226 (2000). (Pubitemid 30453931)
31. Bergeron, R., J. M. Ren, K. S. Cadman, I. K. Moore, P. Perret, M. Pypaert, L. H. Young, C. F. Semenkovich & G. I. Shulman: Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol, 281, E1340-E1158 (2001).
32. Zong, H., J. M. Ren, L. H. Young, M. Pypaert, J. Mu, M. J. Birnbaum & G. I. Shulman: AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci, 99, 15983-15987 (2002). (Pubitemid 35462735)
33. Jorgensen, S. B., J. F. Wojtaszewski, B. Viollet, F. Andreelli, J. B. Birk, Y. Hellsten, P. Schjerling, S. Vaulont, P. D. Neufer, E. A. Richter & H. Pilegaard: Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. Faseb J, 19, 1146-1148 (2005). (Pubitemid 40946446)
34. Jorgensen, S. B., J. T. Treebak, B. Viollet, P. Schjerling, S. Vaulont, J. F. Wojtaszewski & E. A. Richter: Role of {alpha}2-AMPK in basal, training- and AICAR-induced GLUT4, hexokinase II and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab, 292, E331-E339 (2006). (Pubitemid 46052958)
35. Jager, S., C. Handschin, J. St-Pierre & B. M. Spiegelman: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A, 104, 12017-22 (2007). (Pubitemid 47185622)
36. Mu, J., J. T. Brozinick, Jr., O. Valladares, M. Bucan & M. J. Birnbaum: A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell, 7, 1085-94. (2001). (Pubitemid 32525754)
37. Viollet, B., F. Andreelli, S. B. Jorgensen, C. Perrin, A. Geloen, D. Flamez, J. Mu, C. Lenzner, O. Baud, M. Bennoun, E. Gomas, G. Nicolas, J. F. Wojtaszewski, A. Kahn, D. Carling, F. C. Schuit, M. J. Birnbaum, E. A. Richter, R. Burcelin & S. Vaulont: The AMP-activated protein kinase alpha2 catalytic subunit controls wholebody insulin sensitivity. J Clin Invest, 111, 91-8 (2003). (Pubitemid 36134852)
38. Barnes, B. R., S. Marklund, T. L. Steiler, M. Walter, G. Hjalm, V. Amarger, M. Mahlapuu, Y. Leng, C. Johansson, D. Galuska, K. Lindgren, M. Abrink, D. Stapleton, J. R. Zierath & L. Andersson: The AMP-Kgamma 3 isoform has a key role for carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem., 279, 38441-38447 (2004). (Pubitemid 39295995)
39. Witters, L. A., G. Gao, B. E. Kemp & B. Quistorff: Hepatic 5'-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch Biochem Biophys, 308, 413-9 (1994).
40. Witters, L. A. & B. E. Kemp: Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. J Biol Chem, 267, 2864-7 (1992).
41. Lochhead, P. A., I. P. Salt, K. S. Walker, D. G. Hardie & C. Sutherland: 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6- phosphatase. Diabetes, 49, 896-903 (2000). (Pubitemid 30349410)
42. Koo, S. H., L. Flechner, L. Qi, X. Zhang, R. A. Screaton, S. Jeffries, S. Hedrick, W. Xu, F. Boussouar, P. Brindle, H. Takemori & M. Montminy: The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature, 437, 1109-11 (2005).
43. Andreelli, F., M. Foretz, C. Knauf, P. D. Cani, C. Perrin, M. A. Iglesias, B. Pillot, A. Bado, F. Tronche, G. Mithieux, S. Vaulont, R. Burcelin & B. Viollet: Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology, 147, 2432-41 (2006).
44. Minokoshi, Y., T. Alquier, N. Furukawa, Y. B. Kim, A. Lee, B. Xue, J. Mu, F. Foufelle, P. Ferre, M. J. Birnbaum, B. J. Stuck & B. B. Kahn: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature, 428, 569-572 (2004).
45. Lee, K., B. Li, X. Xi, Y. Suh & R. J. Martin: Role of neuronal energy status in the regulation of adenosine 5'- monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology, 146, 3-10 (2005). (Pubitemid 40051714)
46. Kim, E.-K., I. Miller, S. Aja, L. E. Landree, M. Pinn, J. McFadden, F. P. Kuhajda, T. H. Moran & G. V. Ronnett: C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase. J. Biol. Chem., 279, 19970-19976 (2004). (Pubitemid 38623439)
47. Pocai, A., E. D. Muse & L. Rossetti: Did a muscle fuel gauge conquer the brain? Nat Med, 12, 50-1; discussion 51 (2006). (Pubitemid 43050069)
48. Watt, M. J., G. R. Steinberg, Z. P. Chen, B. E. Kemp & M. A. Febbraio: Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes. J Physiol, 574, 139-47 (2006). (Pubitemid 43905803)
49. Kennedy, G. C.: The role of depot fat in the hypothalmic control of food intake in the rat. Proc. R. Soc., 140, 578-592 (1953).
50. Coleman, D. L. & K. P. Hummel: Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol, 217, 1298-1304 (1969).
51. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold & J. M. Friedman: Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-32. (1994). (Pubitemid 24365442)
52. Campfield, L. A., F. J. Smith, Y. Guisez, R. Devos & P. Burn: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science, 269, 546-549 (1995).
53. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley & J. M. Friedman: Weight reducing effects of the plasma protein encoded by the obese gene. Science, 269, 543-546 (1995).
54. Pelleymounter, M. A., M. J. Cullen, B. M. Baker, R. Hecht, D. Winter, T. Boone & F. Collins: Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540-543 (1995).
55. Hotamisligil, G., N. Shargill & B. M. Spiegelman: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259, 87-91 (1993). (Pubitemid 23036092)
56. Hotamisligil, G., D. Murray, L. Choy & B. Spiegelman: Tumor Necrosis Factor {alpha} Inhibits Signaling From the Insulin Receptor. Proc Natl Acad Sci, 91, 4854-4858 (1994). (Pubitemid 24177748)
57. Luca, C., T. J. Kowalski, Y. Zhang, J. K. Elmquist, C. Lee, M. W. Kilmann, T. Ludwig, S. M. Liu & S. C. Chua, Jr.: Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest (2005).
58. Bates, S. H., W. H. Stearns, T. A. Dundon, M. Schubert, A. W. Tso, Y. Wang, A. S. Banks, H. J. Lavery, A. K. Haq, E. Maratos-Flier, B. G. Neel, M. W. Schwartz & M. G. Myers, Jr.: STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature, 421, 856-859 (2003). (Pubitemid 36254146)
59. Tartaglia, L., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G. J. Richards, L. A. Campfield, F. T. Clark, J. Deeds, C. Muir, S. Sanker, A. Moriarty, K. J. Moore, J. S. Smutko, G. G. Mays, E. A. Woolf, C. A. Monroe & R. I. Tepper: Identification and expression cloning of a leptin receptor, OB-R. Cell, 83, 1263-1271 (1995). (Pubitemid 26007816)
60. Muoio, D. M., G. L. Dohm, F. T. J. Fiedorek, E. B. Tapscott & R. A. Coleman: Leptin directly alters lipid partitioning in skeletal muscle. Diabetes, 46, 1360-1363 (1997). (Pubitemid 27315287)
61. Minokoshi, Y., Y. B. Kim, O. D. Peroni, L. G. Fryer, C. Muller, D. Carling & B. B. Kahn: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 415, 339-343 (2002). (Pubitemid 34087557)
62. Suzuki, A., S. Okamoto, S. Lee, K. Saito, T. Shiuchi & Y. Minokoshi: Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol, 27, 4317-27 (2007). (Pubitemid 46906556)
63. Tanaka, T., H. Masuzaki, S. Yasue, K. Ebihara, T. Shiuchi, T. Ishii, N. Arai, M. Hirata, H. Yamamoto, T. Hayashi, K. Hosoda, Y. Minokoshi & K. Nakao: Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet. Cell Metab, 5, 395-402 (2007). (Pubitemid 46667761)
64. Shimabukuro, M., K. Koyama, G. Chen, M.-Y. Wang, F. Trieu, Y. Lee, C. B. Newgard & R. H. Unger: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci, 94, 4637-4641 (1997). (Pubitemid 27194295)
65. Steinberg, G. R., J. W. E. Rush & D. J. Dyck: AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am J Physiol Endocrinol Metab, 284, E648-654 (2003). (Pubitemid 36237554)
66. Steinberg, G. R., A. Bonen & D. J. Dyck: Fatty acid oxidation and triacylglycerol hydrolysis are enhanced following chronic leptin treatment in rats. Am J Physiol, 282, E593-E600 (2002). (Pubitemid 34654775)
67. Lee, Y., X. Yu, F. Gonzales, D. J. Mangelsdorf, M.-Y. Wang, C. Richardson, L. A. Witters & R. H. Unger: PPARalpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc Natl Acad Sci, 99, 11848-11853 (2002). (Pubitemid 34994487)
68. Wang, M. Y., L. Orci, M. Ravazzola & R. H. Unger: Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci U S A, 102, 18011-6 (2005). (Pubitemid 41798493)
69. Orci, L., W. S. Cook, M. Ravazzola, M. Y. Wang, B. H. Park, R. Montesano & R. H. Unger: Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci U S A, 101, 2058-63 (2004). (Pubitemid 38229014)
70. Asilmaz, E., P. Cohen, M. Miyazaki, P. Dobrzyn, K. Ueki, G. Fayzikhodjaeva, A. A. Soukas, C. R. Kahn, J. M. Ntambi, N. D. Socci & J. M. Friedman: Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J. Clin. Invest., 113, 414-424 (2004). (Pubitemid 38544185)
71. Maffei, M., J. Halaas, E. Ravussin, R. E. Pratley, G. H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, P. A. Kern & J. M. Friedman: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med, 1, 1155-1161 (1995).
72. Heymsfield, S. B., A. S. Greenberg, K. Fujioka, R. M. Dixon, R. Kuschner, T. Hunt, J. A. Lubina, J. Patane, B. Self, P. Hunt & M. McCamish: Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escallation trial. JAMA, 282, 1568-1575 (1999). (Pubitemid 29504050)
73. Steinberg, G. R. & D. J. Dyck: Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol, 279, E1374-E1382 (2000).
74. Steinberg, G. R., M. L. Parolin, G. J. Heigenhauser & D. J. Dyck: Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab, 283, E187-92. (2002). (Pubitemid 34686685)
75. Steinberg, G. R., A. C. Smith, B. J. W. van Denderen, Z. Chen, S. Murthy, D. J. Campbell, G. J. F. Heigenhauser, D. J. Dyck & B. E. Kemp: AMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females. J Clin Endocrinol Metab, 89, 4575-4580 (2004). (Pubitemid 39244472)
76. Steinberg, G. R., A. J. McAinch, M. B. Chen, P. E. O'Brien, J. B. Dixon, D. Cameron-Smith & B. E. Kemp: The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab, 91, 3592-7 (2006). (Pubitemid 44402142)
77. Watt, M. J., N. Dzamko, W. G. Thomas, S. Rose-John, M. Ernst, D. Carling, B. E. Kemp, M. A. Febbraio & G. R. Steinberg: CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med, 12, 541-8 (2006).
78. Martin, T. L., T. Alquier, K. Asakura, N. Furukawa, F. Preitner & B. B. Kahn: Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem, 281, 18933-41 (2006). (Pubitemid 44035396)
79. Steinberg, G. R., M. J. Watt, B. C. Fam, J. Proietto, S. Andrikopoulos, A. M. Allen, M. A. Febbraio & B. E. Kemp: Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology, 147, 3906-14 (2006). (Pubitemid 44079396)
80. Bjorbaek, C., J. K. Elmquist, J. D. Frantz, S. E. Shoelson & J. S. Flier: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell, 1, 619-25 (1998). (Pubitemid 128374698)
81. Cheng, A., N. Uetani, P. D. Simoncic, V. P. Chaubey, A. Lee-Loy, C. J. McGlade, B. P. Kennedy & M. L. Tremblay: Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell, 2, 497-503 (2002). (Pubitemid 34436577)
82. Zabolotny, J. M., K. K. Bence-Hanulec, A. Stricker- Krongrad, F. Haj, Y. Wang, Y. Minokoshi, Y. B. Kim, J. K. Elmquist, L. A. Tartaglia, B. B. Kahn & B. G. Neel: PTP1B regulates leptin signal transduction in vivo. Dev Cell, 2, 489-95 (2002). (Pubitemid 34436576)
83. Wormald, S. & D. J. Hilton: Inhibitors of Cytokine Signal Transduction. J. Biol. Chem., 279, 821-824 (2004). (Pubitemid 38082600)
84. Bjorbaek, C., H. J. Lavery, S. H. Bates, R. K. Olson, S. M. Davis, J. S. Flier & M. G. Myers, Jr.: SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985. J Biol Chem, 275, 40649-40657 (2000). (Pubitemid 32064706)
85. Bjorbaek, C., K. El-Haschimi, J. D. Frantz & J. S. Flier: The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem, 274, 30059-65 (1999).
86. Mori, H., R. Hanada, T. Hanada, D. Aki, R. Mashima, H. Nishinakamura, T. Torisu, K. R. Chien, H. Yasukawa & A. Yoshimura: Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity, 10, 739-743 (2004).
87. Howard, J. K., B. J. Cave, L. J. Oksanen, I. Tzameli, C. Bjorbaek & J. S. Flier: Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3, 10, 734-738 (2004).
88. Steinberg, G. R., A. C. Smith, S. Wormald, P. Malenfant, C. Collier & D. J. Dyck: Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am J Physiol Endocrinol Metab, 286, E57-63 (2004). (Pubitemid 38036610)
89. Carey, A. L., G. R. Steinberg, S. L. Macaulay, W. G. Thomas, A. G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M. J. Watt, D. E. James, B. E. Kemp, B. K. Pedersen & M. A. Febbraio: Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase Diabetes, 55, (2006).
90. Namkoong, C., M.-S. Kim, P.-G. Jang, S. M. Han, J.-Y. Park, E. H. Koh, I.-K. Lee, J. Y. Kim, I.-S. Park & K.-U. Lee: Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes, 54, 63-68 (2005). (Pubitemid 40105095)
91. Hu, E., P. Liang & B. M. Spiegelman: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem, 271, 10697-703 (1996). (Pubitemid 26145805)
92. Scherer, P. E., S. Williams, M. Fogliano, G. Baldini & H. F. Lodish: A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes. J. Biol. Chem., 270, 26746-26749 (1995).
93. Barre, L., C. Richardson, M. F. Hirshman, J. T. Brozinick, S. Fiering, B. E. Kemp, L. J. Goodyear & L. A. Witters: A Genetic Model for the Chronic Activation of Skeletal Muscle AMP-activated Protein Kinase Leads to Glycogen Accumulation. Am J Physiol Endocrinol Metab 00369.2.006 (2006).
94. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel & T. Kadowaki: The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 7, 941-946 (2001). (Pubitemid 32756432)
95. Yamauchi, T., J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, S. Uchida, Y. Ito, K. Takakuwa, J. Matsui, M. Takata, K. Eto, Y. Terauchi, K. Komeda, M. Tsunoda, K. Murakami, Y. Ohnishi, T. Naitoh, K. Yamamura, Y. Ueyama, P. Froguel, S. Kimura, R. Nagai & T. Kadowaki: Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis. J. Biol. Chem., 278, 2461-2468 (2003). (Pubitemid 36801322)
96. Ouchi, N., S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamoto, M. Ishigami, H. Kuriyama, K. Kishida, H. Nishizawa, K. Hotta, M. Muraguchi, Y. Ohmoto, S. Yamashita, T. Funahashi & Y. Matsuzawa: Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages. Circulation, 103, 1057-1063 (2001). (Pubitemid 32200177)
97. Masaki, T., S. Chiba, T. Yasuda, T. Tsubone, T. Kakuma, I. Shimomura, T. Funahashi, Y. Matsuzawa & H. Yoshimatsu: Peripheral, But Not Central, Administration of Adiponectin Reduces Visceral Adiposity and Upregulates the Expression of Uncoupling Protein in Agouti Yellow (Ay/a) Obese Mice. Diabetes, 52, 2266-2273 (2003). (Pubitemid 37059496)
98. Fruebis, J., T.-S. Tsao, S. Javorshi, D. Ebbets-Reed, M. R. Erickson, F. T. Yen, B. E. Bihain & H. F. Lodish: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci, 98, 2004-2010 (2001).
99. Lin, H. V., J. Y. Kim, A. Pocai, L. Rossetti, L. Shapiro, P. E. Scherer & D. Accili: Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes, 56, 1969-76 (2007). (Pubitemid 47195822)
100. Wang, C., X. Mao, L. Wang, M. Liu, M. D. Wetzel, K. L. Guan, L. Q. Dong & F. Liu: Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem, 282, 7991-6 (2007). (Pubitemid 47093602)
101. Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B. B. Kahn & T. Kadowaki: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 8, 1288-1295 (2002). (Pubitemid 35373562)
102. Tomas, E., T.-S. Tsao, A. K. Saha, H. E. Murrey, C. c. Zhang, S. I. Itani, H. F. Lodish & N. B. Ruderman: Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A., 99, 16309-16313 (2002). (Pubitemid 35462791)
103. Wu, X., H. Motoshima, K. Mahadev, T. J. Stalker, R. Scalia & B. J. Goldstein: Involvement of AMP-Activated Protein Kinase in Glucose Uptake Stimulated by the Globular Domain of Adiponectin in Primary Rat Adipocytes. Diabetes, 52, 1355-1363 (2003). (Pubitemid 36666188)
104. Hada, Y., T. Yamauchi, H. Waki, A. Tsuchida, K. Hara, H. Yago, O. Miyazaki, H. Ebinuma & T. Kadowaki: Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun, 356, 487-93 (2007). (Pubitemid 46454397)
105. Yamauchi, T., J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N. H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai & T. Kadowaki: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-769 (2003). (Pubitemid 36735700)
106. Debard, C., M. Laville, V. Berbe, E. Loizon, G. C, B. Morio-Liondore, Y. Boirie & H. Vidal: Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetaologia, 47, 816-820 (2004).
107. Civitarese, A. E., C. P. Jenkinson, D. Richardson, M. Bajaj, K. Cusi, S. Kashyap, R. Berria, R. Belfort, R. A. DeFronzo, L. J. Mandarino & E. Ravussin: Adiponectin receptors gene expression and insulin sensitivity in nondiabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia, 47, 816-820 (2004). (Pubitemid 38756993)
108. Staiger, H., S. Kaltenbach, K. Staiger, N. Stefan, A. Fritsche, A. Guirguis, C. Peterfi, M. Weisser, F. Machicao, M. Stumvoll & H.-U. Haring: Expression of Adiponectin Receptor mRNA in Human Skeletal Muscle Cells Is Related to In Vivo Parameters of Glucose and Lipid Metabolism. Diabetes, 53, 2195-2201 (2004). (Pubitemid 39145571)
109. Mao, X., C. K. Kikani, R. A. Riojas, P. Langlais, L. Wang, F. J. Ramos, Q. Fang, C. Y. Christ-Roberts, J. Y. Hong, R. Y. Kim, F. Liu & L. Q. Dong: APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol, 8, 516-23 (2006).
110. Chen, M. B., A. J. McAinch, S. L. Macaulay, L. A. Castelli, E. O'Brien P, J. B. Dixon, D. Cameron-Smith, B. E. Kemp & G. R. Steinberg: Impaired Activation of AMP-Kinase and Fatty Acid Oxidation by Globular Adiponectin in Cultured Human Skeletal Muscle of Obese Type 2 Diabetics. J Clin Endocrinol Metab, 90, 3665-3672 (2005). (Pubitemid 41014341)
111. Bruce, C. R., V. A. Mertz, G. J. Heigenhauser & D. J. Dyck: The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes, 54, 3154-60 (2005). (Pubitemid 43334369)
112. Combs, T. P., A. H. Berg, S. Obici, P. E. Scherer & L. Rossetti: Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest, 108, 1875-81 (2001). (Pubitemid 34015133)
113. Yamauchi, T., Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki & T. Kadowaki: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med, 13, 332-9 (2007). (Pubitemid 46376688)
114. Kubota, N., W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi & T. Kadowaki: Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab, 6, 55-68 (2007). (Pubitemid 47007437)
115. Qi, Y., N. Takahashi, S. M. Hileman, H. R. Patel, A. H. Berg, U. B. Pajvani, P. E. Scherer & R. S. Ahima: Adiponectin acts in the brain to decrease body weight. Nat Med, 10, 524-9 (2004). (Pubitemid 38667912)
116. Steinberg, G. R. & B. E. Kemp: Adiponectin: starving for attention. Cell Metab, 6, 3-4 (2007). (Pubitemid 46995782)
117. Katsuki, A., Y. Sumida, S. Murashima, K. Murata, Y. Takarada, K. Ito, M. Fujii, K. Tsuchihashi, H. Goto, K. Nakatani & Y. Yano: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 83, 859-62. (1998). (Pubitemid 28496458)
118. Zinman, B., A. J. G. Hanley, S. B. Harris, J. Kwan & I. G. Fantus: Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of Type 2 diabetes mellitus. J Clin Endocrinol Metab, 84, 272-278 (1999). (Pubitemid 29036713)
119. Saghizadeh, M., J. M. Ong, W. T. Garvey, R. R. Henry & P. A. Kern: The Expression of TNF-alpha by Human Muscle. Relationship to Insulin Resistance. J. Clin. Invest., 97, 1111-1116 (1996). (Pubitemid 26070591)
120. Kern, P. A., S. Ranganathan, C. Li, L. Wood & G. Ranganathan: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol, 280, E745-E751 (2001).
121. Plomgaard, P., K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J. R. Zierath & B. K. Pedersen: Tumor Necrosis Factor-{alpha} Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation. Diabetes, 54, 2939-45 (2005). (Pubitemid 41401090)
122. Uysal, K. T., S. M. Wiesbrock, M. W. Marino & G. S. Hotamisligil: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 389, 610-4 (1997). (Pubitemid 27446179)
123. Ofei, F., S. Hurel, J. Newkirk, M. Sopwith & R. Taylor: Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes, 45, 881-885 (1996). (Pubitemid 26225502)
124. Gonzalez-Gay, M. A., J. M. De Matias, C. Gonzalez- Juanatey, C. Garcia-Porrua, A. Sanchez-Andrade, J. Martin & J. Llorca: Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol, 24, 83-6 (2006).
125. Bandyopadhyay, G. K., J. G. Yu, J. Ofrecio & J. M. Olefsky: Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects. Diabetes, 55, 2277-85 (2006). (Pubitemid 44743625)
126. Yu, X., S. McCorkle, M. Wang, Y. Lee, J. Li, A. K. Saha, R. H. Unger & N. B. Ruderman: Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetaologia, 47, 2012-2021 (2004). (Pubitemid 40110213)
127. Barnes, B. R., J. W. Ryder, T. L. Steiler, L. G. Fryer, D. Carling & J. R. Zierath: Isoform specific regulation of 5' AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. Diabetes, 51, 2703-2708 (2002). (Pubitemid 34970922)
128. Steinberg, G. R., B. J. Michell, B. J. van Denderen, M. J. Watt, A. L. Carey, B. C. Fam, S. Andrikopoulos, J. Proietto, C. Z. Gorgun, D. Carling, G. S. Hotamisligil, M. A. Febbraio, T. W. Kay & B. E. Kemp: Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab, 4, 465-74 (2006). (Pubitemid 44834113)
129. Gadient, R. A. & P. H. Patterson: Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells, 17, 127-37 (1999). (Pubitemid 29226663)
130. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano & T. Kishimoto: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 58, 573-81 (1989). (Pubitemid 19203542)
131. Boulay, J. L., J. J. O'Shea & W. E. Paul: Molecular phylogeny within type I cytokines and their cognate receptors. Immunity, 19, 159-63 (2003). (Pubitemid 37011330)
132. Ernst, M. & B. J. Jenkins: Acquiring singalling specificity from the cytokine receptor gp130. Trends in Genetics, 20, 23-32 (2004). (Pubitemid 38032817)
133. Lazar, M. A.: How obesity causes diabetes: not a tall tale. Science, 307, 373-375 (2005). (Pubitemid 40139971)
134. Febbraio, M. A. & B. K. Pedersen: Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J., 16, 1335-1347 (2002). (Pubitemid 34913306)
135. Richter, E. A., L. P. Garetto, M. N. Goodman & N. B. Ruderman: Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J Clin Invest, 69, 785-93 (1982). (Pubitemid 12149155)
136. Petersen, E. W., A. L. Carey, M. Sacchetti, G. R. Steinberg, S. L. Macaulay, M. A. Febbraio & B. K. Pedersen: Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol, 288, E155-E162 (2005). (Pubitemid 40023802)
137. van Hall, G., A. Steensberg, M. Sacchetti, C. Fischer, C. Keller, P. Schjerling, N. Hiscock, K. Moller, B. Saltin, M. A. Febbraio & B. K. Pedersen: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab, 88, 3005-10 (2003). (Pubitemid 36877463)
138. Bruce, C. R. & D. J. Dyck: Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin- 6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab, 287, E616-21 (2004). (Pubitemid 39237888)
139. Kelly, M., C. Keller, P. R. Aviluea, P. Keller, Z. Luo, X. Ziang, M. Giralt, J. Hidalgo, A. K. Saha, B. K. Pedersen & N. B. Ruderman: AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun, 320, 449-454 (2004). (Pubitemid 38798888)
140. Al-Khalili, L., K. Bouzakri, S. Glund, F. Lonnqvist, H. A. Koistinen & A. Krook: Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol, 20, 3364-75 (2006). (Pubitemid 44833576)
141. Miller, R. G., J. H. Petajan & W. W. Bryan: A placebo-controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann Neurol, 1996, 256-260 (1996). (Pubitemid 26071576)
142. Lambert, P. D., K. D. Anderson, M. W. Sleeman, V. Wong, J. Tan, A. Hijarunguru, T. L. Corcoran, J. D. Murray, K. E. Thabet, G. D. Yancopoulos & S. J. Wiegand: From the Cover: Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci, 98, 4652-4657 (2001). (Pubitemid 32295031)
143. Gloaguen, I., P. Costa, A. Demartis, D. Lazzaro, A. Di Marco, R. Graziani, G. Paonessa, F. Chen, C. I. Rosenblum, L. H. T. Van der Ploeg, R. Cortese, G. Ciliberto & R. Laufer: Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. PNAS, 94, 6456-6461 (1997). (Pubitemid 27270706)
144. Sleeman, M. W., K. Garcia, R. Liu, J. D. Murray, L. Malinova, M. Moncrieffe, G. D. Yancopoulos & S. J. Wiegand: Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice. PNAS, 100, 14297-14302 (2003). (Pubitemid 37499231)
145. Ettinger, M., T. Littlejohn, S. Schwartz, S. Weiss, H. McIlwain, S. Heymsfield, G. Bray, W. Roberts, E. Heyman, N. Stambler, S. Heshka, C. Vicary & H. Guler: Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA, 289, 1826-1832 (2003). (Pubitemid 37430253)
146. Kelly, J. F., C. F. Elias, C. E. Lee, R. S. Ahima, R. J. Seeley, C. Bjorbaek, T. Oka, C. B. Saper, J. S. Flier & J. K. Elmquist: Ciliary Neurotrophic Factor and Leptin Induce Distinct Patterns of Immediate Early Gene Expression in the Brain. Diabetes, 53, 911-920 (2004). (Pubitemid 38436602)
147. Kokoeva, M. V., H. Yin & J. S. Flier: Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science, 310, 679-83 (2005). (Pubitemid 41528161)
148. Watt, M. J., A. Hevener, G. I. Lancaster & M. A. Febbraio: Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of JNK in peripheral tissues. Endocrinology, 147, 2077-2085 (2006).
149. Anderson, K. D., P. D. Lambert, T. L. Corcoran, J. D. Murray, K. E. Thabet, G. D. Yancopoulos & S. J. Wiegand: Activation of the Hypothalamic Arcuate Nucleus Predicts the Anorectic Actions of Ciliary Neurotrophic Factor and Leptin in Intact and Gold Thioglucose-Lesioned Mice. J Neuroendocrinol, 15, 649-660 (2003). (Pubitemid 36789964)
150. Schwartz, M. W. & D. Porte: Diabetes, Obesity and the Brain. Science, 307, 375-379 (2005).
151. Frederich, R. C., A. Hamann, S. Anderson, B. Lollmann, B. B. Lowell & J. S. Flier: Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med, 1, 1311-1314 (1995).
152. Bluher, S., S. Moschos, J. J. Bullen, E. Kokkotou, E. Maratos-Flier, S. Wiegand, M. Sleeman & C. Mantzoros: Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes, 53, 2787-2796 (2004). (Pubitemid 39425903)
153. Steppan, C. M., S. T. Bailey, S. Bhat, E. J. Brown, R. R. Banerjee, C. M. Wright, H. R. Patel, R. S. Ahima & M. A. Lazar: The hormone resistin links obesity to diabetes. Nature, 409, 307-12 (2001). (Pubitemid 32151228)
154. Qi, Y., Z. Nie, Y. S. Lee, N. S. Singhal, P. E. Scherer, M. A. Lazar & R. S. Ahima: Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes, 55, 3083-90 (2006). (Pubitemid 44923646)
155. Banerjee, R. R., S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, C. M. Steppan, R. S. Ahima, S. Obici, L. Rossetti & M. A. Lazar: Regulation of Fasted Blood Glucose by Resistin. Science, 303, 1195-1198 (2004). (Pubitemid 38233585)
156. Satoh, H., M. T. A. Nguyen, P. D. G. Miles, T. Imamura, I. Usui & J. M. Olefsky: Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest., 114, 224-231 (2004). (Pubitemid 39071627)
157. Palanivel, R. & G. Sweeney: Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett, 579, 5049-54 (2005). (Pubitemid 41242851)
158. Steppan, C. M., J. Wang, E. L. Whiteman, M. J. Birnbaum & M. A. Lazar: Activation of SOCS-3 by resistin. Mol Cell Biol, 25, 1569-75 (2005). (Pubitemid 40204931)
159. Nakazato, M., N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa & S. Matsukura: A role for ghrelin in the central regulation of feeding. Nature, 409, 194-198 (2001). (Pubitemid 32144284)
160. Andersson, U., K. Filipsson, C. R. Abbott, A. Woods, K. Smith, S. R. Bloom, D. Carling & C. J. Small: AMP-activated Protein Kinase Plays a Role in the Control of Food Intake. J. Biol. Chem., 279, 12005-12008 (2004). (Pubitemid 38445761)
161. Kola, B., E. Hubina, S. A. Tucci, T. C. Kirkham, E. A. Garcia, S. E. Mitchell, L. M. Williams, S. A. Hawley, D. G. Hardie, A. B. Grossman & M. Korbonits: Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem, 280, 25196-201 (2005). (Pubitemid 40934612)
162. Barazzoni, R., A. Bosutti, M. Stebel, M. R. Cattin, E. Roder, L. Visintin, L. Cattin, G. Biolo, M. Zanetti & G. Guarnieri: Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab, 288, E228-35 (2005). (Pubitemid 40023812)
163. Howard, A. D., S. D. Feighner, D. F. Cully, J. P. Arena, P. A. Liberator, C. I. Rosenblum, M. Hamelin, D. L. Hreniuk, O. C. Palyha, J. Anderson, P. S. Paress, C. Diaz, M. Chou, K. K. Liu, K. K. McKee, S. S. Pong, L. Y. Chaung, A. Elbrecht, M. Dashkevicz, R. Heavens, M. Rigby, D. J. Sirinathsinghji, D. C. Dean, D. G. Melillo, A. A. Patchett, R. Nargund, P. R. Griffin, J. A. DeMartino, S. K. Gupta, J. M. Schaeffer, R. G. Smith & L. H. Van der Ploeg: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 273, 974-7 (1996). (Pubitemid 26275178)
164. Rangwala, S. M., A. S. Rich, B. Rhoades, J. S. Shapiro, S. Obici, L. Rossetti & M. A. Lazar: Abnormal Glucose Homeostasis due to Chronic Hyperresistinemia. Diabetes 53, 1937-41 (2004). (Pubitemid 38970738)
165. Glund, S., A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath & A. Krook: Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes, 56, 1630-7 (2007). (Pubitemid 46842596)